“…Discovery of ASFV gene function via genetic manipulation has enabled the production of experimental live-attenuated ASFV vaccine candidates by different research groups [ 3 , 4 , 5 , 6 , 7 , 8 , 9 , 25 ]. Interestingly, just a small number of virus genes have been successfully deleted from the ASFV genome, producing a novel recombinant virus (e.g., 9GL, UK, TK, MGF, NL, CD2, Lectin, DP148R, I177L, and C962R) [ 4 , 5 , 6 , 7 , 8 , 18 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]), and another small number of genes were determined to be essential for virus replication (e.g., EP152R, p30, p54, and p72) [ 27 , 33 , 34 , 35 ]. The absence of experimental information restricts the knowledge for most ASFV proteins to ORF analysis by functional genomics, predicting the functions of these ORFs.…”